The in vivo study of inflammasome NOD-like receptor protein 3 (NLRP3) as a starting point for the development of new innovative migraine drugs
FENS Forum 2024 · University Hospital of Ferrara
Jun 25, 2024
Simona Stragapede
University Hospital of Ferrara,
1 poster